Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-15
Corpus(Cr.) 1511.00 Latest NAV 31.6903 As on 29-10-2026
Equity(%) 99.72 52 Week High 34.0013
Debt(%) 0.28 52 Week Low 27.913
Others(%) 0.00 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.18%
Top 10 Holdings 50.53%
Top 25 Holdings 86.05%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 60.64
Healthcare 28.33
Fertilisers 6.93
Chemicals 2.59
FMCG 1.23
Cash 0.28
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.52
PE Ratio 40.30
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 7.99
Abbott India Ltd. 5.94
HealthCare Global Enterprises Limited 5.92
Divis Laboratories Ltd. 5.68
Dr. Reddys Laboratories Ltd. 4.65
Apollo Hospitals Enterprises Ltd. 4.36
Rainbow Childrens Medicare Limited 4.30
Cipla Ltd. 4.22
Torrent Pharmaceuticals Ltd. 3.76
Max Healthcare Institute Limited 3.71
Lupin Ltd 3.14
Bayer CropScience Limited. 2.96
Syngene International Limited 2.85
PROCTER & GAMBLE HEALTH LIMITED 2.75
Sai Life Sciences Limited 2.60
PI Industries Limited 2.59
Anthem Biosciences Limited 2.57
Pfizer Ltd. 2.50
Alkem Laboratories Limited 2.36
FDC Ltd. 2.24
ACUTAAS CHEMICALS LIMITED 1.95
Fortis Healthcare Ltd 1.95
Dr. Lal Pathlabs Limited 1.76
Aster DM Healthcare Limited 1.67
Ajanta Pharma Ltd. 1.63

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-4.09% -6.05% 5.67% 1.92%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Pharma]
-0.83% 1.28% 14.83% 19.08%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
2.13% 17.35% 13.10% 12.80%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
8.71% 21.85% 13.98% 8.72%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 16.71% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection